Alibaba has introduced a new artificial intelligence model aimed at tackling fatty liver disease, a growing health concern. Bloomberg posted on X, highlighting the potential of hospital data at scale to aid in prevention efforts. The AI model is designed to analyze extensive medical data to identify patterns and risk factors associated with the disease, which is becoming increasingly prevalent globally. This initiative underscores the role of AI in healthcare, offering innovative solutions to complex medical challenges. Alibaba's approach demonstrates the potential for technology to enhance disease prevention and management, leveraging data-driven insights to improve patient outcomes.